EyePoint Pharmaceuticals, Inc. — Director's Dealing 2008

Jun 27, 2008

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2008-06-19

Reporting Person: ROGERS MICHAEL W (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase CHESS Depositary Interests ("CDI's")	$34.9563	2010-09-30	CDIs (5000)		Direct
Option to purchase CDIs	$5.2245	2012-09-30	CDIs (18750)		Direct

Footnotes

F1: 6,250 options vest on October 18, 2008, another 6,250 options vest on October 18, 2009, and the final 6,250 options vest on October 18, 2010.

F2: Each CDI represents an interest in one underlying share of common stock of pSivida Corp.

F3: Per CDI. The exercise price was converted from A$0.92 using the noon-day rate of exchange of the Federal Reserve Bank of New York on June 19, 2008, which was US$0.9499 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.

F4: Per CDI. The exercise price was converted from A$0.1375 using the noon-day rate of exchange of the Federal Reserve Bank of New York on June 19, 2008, which was US$0.9499 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.